Breaking News, Collaborations & Alliances

AZ, CrystalGenomics Enter Antibiotic Pact

AstraZeneca and Korea-based CrystalGenomics have entered into a research collaboration to discover and develop a novel anti-infective for use as a potential antibacterial agent.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca and Korea-based CrystalGenomics have entered into a research collaboration to discover and develop a novel anti-infective for use as a potential antibacterial agent. CrystalGenomics will receive research funding from AZ for two years and will be eligible to receive future milestones and royalty payments associated with development and commercialization of a drug candidate. Financial terms were not disclosed. CrystalGenomics will use its structure-based drug discovery platform tech...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters